Cision PR Newswire

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...

Youlife Group Inc. Reschedules FY2025 Earnings Conference Call to April 28 at 9 AM ET

SHANGHAI, April 25, 2026 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced...

Hindustan Zinc clocks record Q4 net profit of US$ 550 million, up 68% YoY; EBITDA at US$ 847 million, driven by efficiency-led growth

UDAIPUR, India, April 25, 2026 /PRNewswire/ -- India-based Hindustan Zinc Limited, a Vedanta Group company and the world's largest integrated zinc producer, announced its...

/C O R R E C T I O N — Flexsys/

In the news release, FLEXSYS TO INCREASE PRICES FOR INSOLUBLE SULFUR IN INDIA, issued 22-Apr-2026 by Flexsys over PR Newswire, we are advised by...